Acta Neuropathol
- BALUSU S, De Strooper B
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's
disease.
Acta Neuropathol. 2024;147:96.
- GAO F, Zhang M, Wang Q, Ni M, et al
Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and
cognition in Alzheimer's disease.
Acta Neuropathol. 2024;147:97.
- SARKANY B, David C, Hortobagyi T, Gombas P, et al
Early and selective localization of tau filaments to glutamatergic subcellular
domains within the human anterodorsal thalamus.
Acta Neuropathol. 2024;147:98.
Alzheimers Dement
- OVEISGHARAN S, Yu L, de Paiva Lopes K, Tasaki S, et al
Proteins linking APOE varepsilon4 with Alzheimer's disease.
Alzheimers Dement. 2024 Jun 10. doi: 10.1002/alz.13867.
- YEW PY, Devera R, Liang Y, Khalifa RAE, et al
Unraveling the multiple chronic conditions patterns among people with Alzheimer's
disease and related dementia: A machine learning approach to incorporate
synergistic interactions.
Alzheimers Dement. 2024 Jun 11. doi: 10.1002/alz.13923.
- LEE JK, Raghavan S, Christenson LR, Frank RD, et al
Longitudinal associations of reproductive factors and exogeneous estrogens with
neuroimaging biomarkers of Alzheimer's disease and cerebrovascular disease.
Alzheimers Dement. 2024 Jun 11. doi: 10.1002/alz.13890.
- LIU Y, Xiao X, Yang Y, Yao R, et al
The risk of Alzheimer's disease and cognitive impairment characteristics in eight
mental disorders: A UK Biobank observational study and Mendelian randomization
analysis.
Alzheimers Dement. 2024 Jun 11. doi: 10.1002/alz.14049.
- DING X, Yin L, Zhang L, Zhang Y, et al
Diabetes accelerates Alzheimer's disease progression in the first year post mild
cognitive impairment diagnosis.
Alzheimers Dement. 2024 Jun 12. doi: 10.1002/alz.13882.
- BERRON D, Olsson E, Andersson F, Janelidze S, et al
Remote and unsupervised digital memory assessments can reliably detect cognitive
impairment in Alzheimer's disease.
Alzheimers Dement. 2024 Jun 12. doi: 10.1002/alz.13919.
Biol Psychiatry
- HUO Y, Jing R, Li P, Chen P, et al
Delineating the Heterogeneity of Alzheimer's Disease and Mild Cognitive
Impairment Using Normative Models of the Dynamic Brain Functional Networks.
Biol Psychiatry. 2024 Jun 8:S0006-3223(24)01365.
BMC Neurol
- ZHU W, Zhou X, Ren M, Yin W, et al
Process approach as a cognitive biomarker related to gray matter volume in mild
cognitive impairment and Alzheimer's disease.
BMC Neurol. 2024;24:199.
Brain Res
- MCCLARTY BM, Rodriguez G, Dong H
Class 1 histone deacetylases differentially modulate memory and synaptic genes in
a spatial and temporal manner in aged and APP/PS1 mice.
Brain Res. 2024;1837:148951.
- WANG Y, Wu LH, Hou F, Wang ZJ, et al
Mitochondrial calcium uniporter knockdown in hippocampal neurons alleviates
anxious and depressive behavior in the 3XTG Alzheimer's disease mouse model.
Brain Res. 2024 Jun 6:149060. doi: 10.1016/j.brainres.2024.149060.
- RUSSO ML, Ayala G, Neal D, Rogalsky AE, et al
Alzheimer's-linked axonal changes accompany elevated antidromic action potential
failure rate in aged mice.
Brain Res. 2024 Jun 10:149083. doi: 10.1016/j.brainres.2024.149083.
Dement Geriatr Cogn Disord
- CHO BH, Kim H, Choi SM, Cho SH, et al
Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease
dementia and Dementia with Lewy bodies in Korean patient cohort.
Dement Geriatr Cogn Disord. 2024 Jun 8. doi: 10.1159/000539743.
J Alzheimers Dis
- SUGANUMA T, Hatori S, Chen CK, Hori S, et al
Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice
Without Reducing the Amyloid-beta Plaque Burden.
J Alzheimers Dis. 2024;99:1285-1301.
- FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and
Alzheimer's Disease by Selected Reaction Monitoring.
J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
- LIANG X, Wang Y, Li S, Fan J, et al
Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in
Alzheimer's Disease Models.
J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
- TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things
Stand and Are Headed.
J Alzheimers Dis. 2024;99:1159-1171.
- TAYLOR J, Jaros M, Chen C, Harrison J, et al
Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled
Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
- LI D, Xie Q, Xie J, Ni M, et al
Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset
Alzheimer's Disease.
J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
- CANTERO-FORTIZ Y, Cano A, Boada M
Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's
Disease.
J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
- SUN CK, Guo F, Ou YN, Zhang MZ, et al
Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid
Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
- CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
- LI JG, Mutreja Y, Servili M, Leone A, et al
The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple
Transgenic Mouse Model of Alzheimer's Disease.
J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
-
Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy
Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.
- DESAI S, Chen IY, Hom C, Doran E, et al
Insomnia Symptoms Are Associated with Measures of Functional Deterioration and
Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's
Disease.
J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
- CHANDLER JM, Ye W, Mi X, Doty EG, et al
Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's
Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs:
Estimates Based on Findings from GERAS-US Study.
J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
- CHEN X, Walton K, Brodaty H, Chalton K, et al
Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in
Alzheimer's Disease: Findings from Clinical Trials.
J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
- LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in
Older Adults with and without Alzheimer's Disease.
J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
- CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and
Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the
COMPASS-ND Study.
J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
- SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's
Disease.
J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
- CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of
Mitochondria.
J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
- WANG T, Zhang W, Maclin JMA, Xu H, et al
Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild
Cognitive Impairment in Peripheral Blood.
J Alzheimers Dis. 2024;99:1385-1396.
- XIONG R, Li B, Yu H, Fan T, et al
Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1
Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
J Alzheimers Dis. 2024;99:1303-1316.
J Neurol Neurosurg Psychiatry
- DOBSON R, Patterson K, Malik R, Mandal U, et al
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies
for Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333468.
- UNDERWOOD BR
Predicting how many people might receive treatment with new therapies for
Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333941.
J Neurosci
- MURAKAMI R, Watanabe H, Hashimoto H, Kashiwagi-Hakozaki M, et al
Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau
propagation using human pluripotent stem cell-derived models.
J Neurosci. 2024 Apr 22:e1709232024. doi: 10.1523/JNEUROSCI.1709-23.2024.
Nat Rev Neurol
- MIELKE MM, Fowler NR
Alzheimer disease blood biomarkers: considerations for population-level use.
Nat Rev Neurol. 2024 Jun 11. doi: 10.1038/s41582-024-00989.
- SCHINDLER SE, Galasko D, Pereira AC, Rabinovici GD, et al
Acceptable performance of blood biomarker tests of amyloid pathology -
recommendations from the Global CEO Initiative on Alzheimer's Disease.
Nat Rev Neurol. 2024 Jun 12. doi: 10.1038/s41582-024-00977.
Nature
- GRAHAM F
Daily briefing: Landmark Alzheimer's paper will be retracted.
Nature. 2024 Jun 5. doi: 10.1038/d41586-024-01699.
- REARDON S
Alzheimer's drug with modest benefits wins backing of FDA advisers.
Nature. 2024 Jun 10. doi: 10.1038/d41586-024-01726.
Neurobiol Aging
- CAVALLARI M, Touroutoglou A, Katsumi Y, Fong TG, et al
Relationship between cortical brain atrophy, delirium, and long-term cognitive
decline in older surgical patients.
Neurobiol Aging. 2024;140:130-139.
- LIBRI I, Silvestri C, Caratozzolo S, Alberici A, et al
Association of APOE genotype with blood-brain barrier permeability in
neurodegenerative disorders.
Neurobiol Aging. 2024;140:33-40.
Neurology
- MASTENBROEK SE, Sala A, Vallez Garcia D, Shekari M, et al
Continuous beta-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease
Heterogeneity.
Neurology. 2024;103:e209419.
- HAMILTON CA, Donaghy PC, Durcan R, Ciafone J, et al
Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer
Disease at 3 and 5 Years After Diagnosis.
Neurology. 2024;103:e209499.
Neurosci Lett
- SMITH AS, Subramanian J, Doderer J, Moskovitz J, et al
Methionine oxidation of clusterin in Alzheimer's disease and its effect on
clusterin's binding to beta-amyloid.
Neurosci Lett. 2024;836:137874.
- CHITTORA R, Jain S, Roy A, Pandey S, et al
Multifactorial effects of short duration early exposure low intensity magnetic
field stimulation in Streptozotocin induced Alzheimer's disease rat model.
Neurosci Lett. 2024;836:137878.
Neuroscience
- AHMAD RATHER M, Khan A, Jahan S, Jamal Siddiqui A, et al
Influence of Tau on neurotoxicity and cerebral vasculature impairment associated
with Alzheimer's disease.
Neuroscience. 2024 Jun 11:S0306-4522(24)00252.
PLoS One
- LIAO K, Lou Q
Alzheimer's disease increases the risk of erectile dysfunction independent of
cardiovascular diseases: A mendelian randomization study.
PLoS One. 2024;19:e0303338.
- SANO M, Nishiura Y, Morikawa I, Hoshino A, et al
Analysis of the alpha activity envelope in electroencephalography in relation to
the ratio of excitatory to inhibitory neural activity.
PLoS One. 2024;19:e0305082.
Proc Natl Acad Sci U S A
- AXELL E, Hu J, Lindberg M, Dear AJ, et al
The role of shear forces in primary and secondary nucleation of amyloid fibrils.
Proc Natl Acad Sci U S A. 2024;121:e2322572121.
Science
- COUZIN-FRANKEL J
New Alzheimer's drug clears FDA advisory vote despite unknowns.
Science. 2024;384:1164-1165.
- PARK J, Wang J, Guan W, Gjesteby LA, et al
Integrated platform for multiscale molecular imaging and phenotyping of the human
brain.
Science. 2024;384:eadh9979.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016